Atomistry » Iron » PDB 3qjt-3r0g » 3qoa
Atomistry »
  Iron »
    PDB 3qjt-3r0g »
      3qoa »

Iron in PDB 3qoa: Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine.

Enzymatic activity of Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine.

All present enzymatic activity of Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine.:
1.14.14.1;

Protein crystallography data

The structure of Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine., PDB code: 3qoa was solved by M.B.Shah, J.Pascual, C.D.Stout, J.R.Halpert, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 50.34 / 2.10
Space group P 32 2 1
Cell size a, b, c (Å), α, β, γ (°) 76.760, 76.760, 201.341, 90.00, 90.00, 120.00
R / Rfree (%) 19.7 / 25

Iron Binding Sites:

The binding sites of Iron atom in the Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine. (pdb code 3qoa). This binding sites where shown within 5.0 Angstroms radius around Iron atom.
In total only one binding site of Iron was determined in the Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine., PDB code: 3qoa:

Iron binding site 1 out of 1 in 3qoa

Go back to Iron Binding Sites List in 3qoa
Iron binding site 1 out of 1 in the Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine.


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 1 of Crystal Structure of A Human Cytochrome P450 2B6 (Y226H/K262R) in Complex with the Inhibitor 4-Benzylpyridine. within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Fe500

b:17.6
occ:1.00
FE A:HEM500 0.0 17.6 1.0
NA A:HEM500 1.8 18.0 1.0
NB A:HEM500 1.9 20.5 1.0
NC A:HEM500 2.0 16.8 1.0
ND A:HEM500 2.1 19.2 1.0
SG A:CYS436 2.3 16.4 1.0
NAK A:3QO501 2.4 35.8 1.0
C1A A:HEM500 2.9 17.2 1.0
C4A A:HEM500 2.9 14.2 1.0
C4C A:HEM500 3.0 16.0 1.0
C4B A:HEM500 3.0 17.2 1.0
C1B A:HEM500 3.0 17.9 1.0
C1C A:HEM500 3.0 14.5 1.0
C4D A:HEM500 3.0 17.8 1.0
CAE A:3QO501 3.0 34.2 1.0
C1D A:HEM500 3.1 16.1 1.0
CB A:CYS436 3.2 18.6 1.0
CHA A:HEM500 3.3 19.0 1.0
CAD A:3QO501 3.3 33.8 1.0
CHB A:HEM500 3.3 16.4 1.0
CHC A:HEM500 3.3 15.3 1.0
CHD A:HEM500 3.3 14.9 1.0
CA A:CYS436 4.0 17.4 1.0
C3A A:HEM500 4.1 11.9 1.0
C2A A:HEM500 4.1 14.2 1.0
C3C A:HEM500 4.1 15.6 1.0
C3B A:HEM500 4.2 15.1 1.0
C2C A:HEM500 4.2 17.3 1.0
C2B A:HEM500 4.2 16.7 1.0
C3D A:HEM500 4.3 12.5 1.0
C2D A:HEM500 4.3 17.6 1.0
CAI A:3QO501 4.4 31.5 1.0
CAH A:3QO501 4.6 31.3 1.0
C A:CYS436 4.7 17.7 1.0
N A:GLY438 4.7 14.6 1.0
N A:LEU437 4.7 17.0 1.0
CG2 A:THR302 4.9 22.2 1.0
CAM A:3QO501 5.0 31.5 1.0

Reference:

M.B.Shah, J.Pascual, Q.Zhang, C.D.Stout, J.R.Halpert. Structures of Cytochrome P450 2B6 Bound to 4-Benzylpyridine and 4-(4-Nitrobenzyl)Pyridine: Insight Into Inhibitor Binding and Rearrangement of Active Site Side Chains. Mol.Pharmacol. V. 80 1047 2011.
ISSN: ISSN 0026-895X
PubMed: 21875942
DOI: 10.1124/MOL.111.074427
Page generated: Sun Dec 13 15:19:19 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy